Marex Group’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-6,550
Closed -$604K – 1143
2025
Q4
$604K Sell
6,550
-1,901
-22% -$182K ﹤0.01% 508
2025
Q3
$627K Buy
8,451
+4,279
+103% +$433K ﹤0.01% 442
2025
Q2
$541K Buy
4,172
+2,543
+156% +$369K ﹤0.01% 367
2025
Q1
$259K Buy
1,629
+540
+50% +$97.7K 0.01% 501
2024
Q4
$202K Buy
+1,089
New +$211K ﹤0.01% 551

Other funds holding INSP

Marex Group's INSP Position: Q1 2026 in Review

Marex Group sold out of Inspire Medical Systems (INSP) in Q1 2026, closing a stake of 6,550 shares — an estimated $604K sold.

Marex Group first reported a position in INSP in Q4 2024 and held it in 5 quarters. The position peaked at $627K in Q3 2025. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

  • Marex Group reported no remaining Inspire Medical Systems position as of Q1 2026 after selling out during the quarter.
  • Marex Group sold 6,550 Inspire Medical Systems shares in Q1 2026, an estimated $604K.
  • Marex Group first reported a position in Inspire Medical Systems in Q4 2024 and held it in 5 quarters.
  • Marex Group's Inspire Medical Systems position peaked at $627K in Q3 2025.
  • 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.